drugset / Trial / NCT06955754

A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food

NCT06955754 ↗

Phase 1 Completed 16 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

This trial aims to investigate the relative bioavailability of three different oral formulations of BI 764198 and how this is influenced by food.

Timeline

Start
2025-05-20
Primary completion
2025-06-26
Completion
2025-07-14

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 764198 Unknown — Oral

Indications

No indication recorded.